Hercules, CA — June 6, 2011 — Bio-Rad Laboratories, Inc.'s new software for the ProteOn™ XPR36 protein interaction array system, ProteOn Manager software 3.0, enhances researchers’ ability to analyze protein interactions using surface plasmon resonance (SPR). This new software streamlines experimental set up and data analysis with new features that make the ProteOn system easier to use with reduced hands-on time. This version is a free upgrade for ProteOn system customers.
Two new features of the software, Automated Protocol Creation and Protocol Check Quick View, reduce experiment set up time. ProteOn Manager Software 3.0 automatically creates a protocol as researchers import their sample data layout. Researchers can then quickly review all sample and injection parameters in one easy-to-customize table view.
“Bio-Rad’s ProteOn has been invaluable in generating kinetic parameters to help us study all sorts of protein interactions,” said Marco Gobbi, Laboratory Head at the Mario Negri Institute for Pharmacological Research in Milano, Italy. “The software enhancements take a great instrument and make it even easier to use.”
Data analysis is made simpler with ProteOn Manager software 3.0. Users can customize results tables and select only the fields they want to view. Reports are equally customizable so that only essential data and sensorgrams may be printed. Additional features and benefits of the ProteOn Manager software 3.0 include:
- Off-rate only kinetic analysis — allows kinetic data to be determined independent of analyte concentration
- Location independent double reference — gives researchers the flexibility to choose multiple reference locations in a single experiment increasing data quality and experimental flexibility
- Cleaning wizard — automatically prompts and guides users through a post-experiment cleanup procedure to ensure optimum performance every run
For more information on ProteOn Software Manager 3.0, visit http://bit.ly/ProteOn_Manager_3.
About the ProteOn XPR36 Protein Interaction Array System
The ProteOn XPR36 protein interaction array system is a multiplexed SPR biosensor that allows users to simultaneously measure the interactions of six different ligand proteins with panels of six different concentrations of analyte, obtaining comprehensive kinetic profiles in a single experiment without the need for regeneration. Utilizing a novel optical design and state-of-the-art microfluidics, the ProteOn XPR36 system provides much higher throughput for rapid screening of protein interactions than traditional SPR devices.
Biologics, such as antibodies, are vital reagents in basic biomedical research and for the diagnosis and treatment of various diseases. A number of antibodies are currently being used to treat diseases such as cancer, arthritis, and Crohn’s disease. Screening, profiling, and characterizing antibodies can often be tedious and time-consuming. The ProteOn XPR36 system reduces the amount of time required for screening targets, optimizing assay design, and profiling and characterizing antibody interactions.
The ProteOn XPR36 system is ideal for scientists conducting antibody research in drug discovery and development. Key application areas for these customers include protein interface analysis, interaction proteomics, and drug target interactions.
To obtain technical articles, go to www.bio-rad.com/osk.
About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) has remained at the center of scientific discovery for more than 50 years, manufacturing and distributing a broad range of products for the life science research and clinical diagnostic markets. The company is renowned worldwide among hospitals, universities, and major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. Founded in 1952, Bio-Rad is headquartered in Hercules, California, and serves more than 100,000 research and industry customers worldwide through its global network of operations. The company employs more than 6,800 people globally and had revenues exceeding $1.9 billion in 2010. For more information, please visit http://www.biorad.com.
For more information contact:
Laura Moriarty
Bio-Rad Laboratories, Inc.
510-741-4017
Laura_Moriarty@bio-rad.com.
Ken Li
Chempetitive Group
312-997-2436 x 109
kli@chempetitive.com
